Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing

Bibliographic Details
Main Authors:	Wang Shixia, Krachmarov Chavdar, Sharpe-Cohen Sandra, Zolla-Pazner Susan, Pinter Abraham, Lu Shan
Format:	Article
Language:	English
Published:	BMC 2006-12-01
Series:	Retrovirology

Similar Items

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
by: Wang S, et al.
Published: (2009-10-01)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
by: Spearman P, et al.
Published: (2012-09-01)

Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects.
by: Evgeny Shmelkov, et al.
Published: (2011-01-01)

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay
by: Rao M, et al.
Published: (2012-09-01)

Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes.
by: James Swetnam, et al.
Published: (2010-12-01)

Immunogenicity of the outer domain of a HIV-1 clade C gp120
by: Xu Xiaodong, et al.
Published: (2007-05-01)

Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies.
by: Evgeny Shmelkov, et al.
Published: (2014-01-01)

The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies
by: Dueñas-Decamp Maria J, et al.
Published: (2012-01-01)

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
by: Kristina K Peachman, et al.
Published: (2015-01-01)

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
by: Moore, J, et al.
Published: (1995)

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.
by: Sattentau, Q, et al.
Published: (1995)

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.
by: Johannes S Gach, et al.
Published: (2013-01-01)

Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
by: Birco Schwalbe, et al.
Published: (2015-01-01)

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.
by: Mondor, I, et al.
Published: (1998)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

Conservation of HIV-1 gp120 neutralizing epitopes after formalin inactivation.
by: Sattentau, Q
Published: (1995)

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
by: Susan Zolla-Pazner, et al.
Published: (2014-11-01)

Characterization of RNA aptamers that bind to HIV-1 gp120
by: Cohen, C
Published: (2006)

Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.
by: Phanourios Tamamis, et al.
Published: (2014-01-01)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
by: Nika M. Strokappe, et al.
Published: (2019-06-01)

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
by: Sattentau, Q, et al.
Published: (1995)

Engineering of HIV gp120 by yeast surface display for neutralizing antibody characterization and immunogen design
by: Mata-Fink, Jordi
Published: (2013)

Fusion Complexes and CD4-independent gp120s for the Induction of HIV-1 Neutralizing Antibodies
by: Lopalco L, et al.
Published: (2005-12-01)

Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.
by: Masaru Yokoyama, et al.
Published: (2012-01-01)

Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage.
by: Oliver Sander, et al.
Published: (2007-03-01)

An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site
by: Cohen, C, et al.
Published: (2008)

Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.
by: Yali Qin, et al.
Published: (2015-01-01)

Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1
by: Dey, AK, et al.
Published: (2005)

Characterization of gp120 and Its Single-chain Derivatives, gp120-CD4 and gp120-M9: Implications for Targeting the CD4i Epitope in HIV-1 Vaccine Design
by: Shiver John
Published: (2005-12-01)

The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.
by: Natasha T Wood, et al.
Published: (2013-01-01)

Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop
by: Ling-ling Shen, et al.
Published: (2015-01-01)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.
by: Sakaorat Lertjuthaporn, et al.
Published: (2018-08-01)

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein.
by: Jianhui Tian, et al.
Published: (2016-10-01)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.
by: Poignard, P, et al.
Published: (1996)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
by: Emaya M. Moss, et al.
Published: (2023-02-01)

Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.
by: Boonrat Tassaneetrithep, et al.
Published: (2014-01-01)

Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops.
by: Aliana López de Victoria, et al.
Published: (2012-01-01)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
by: Visciano Maria, et al.
Published: (2006-12-01)

Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
by: Moore, J, et al.
Published: (1990)